Latest Articles
- ArticleNeurochondrin is a neuronal target antigen in autoimmune cerebellar degenerationRamona Miske, Catharina C. Gross, Madeleine Scharf, et al.December 05, 2016
- ArticleIsolated dysphagia as initial sign of anti-IgLON5 syndromeJens Burchard Schröder, Nico Melzer, Tobias Ruck, et al.November 22, 2016
- ArticleBlood–brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIVBirgitta Anesten, Aylin Yilmaz, Lars Hagberg, et al.November 09, 2016
- ArticleTargeted treatment of brainstem neurohistiocytosis guided by urinary cell-free DNADavid Hunt, Paul Milne, Peter Fernandes, et al.November 03, 2016
- Clinical/Scientific NotesAsymptomatic CNS demyelination related to TNF-α inhibitor therapyFarwa Ali, Ruple S. LaughlinOctober 28, 2016
- Clinical/Scientific NotesParoxysmal sneezing in NMOSD: Further evidence of the localization of the human sneeze centerA. Sebastian López-Chiriboga, Josephine F. Huang, Eoin P. Flanagan, et al.October 28, 2016
- Clinical/Scientific NotesA comparison of tissue-based and recombinant protein–based assays for detecting PCA-Tr/DNER-IgGNora Alfugham, Matthew Roforth, Lars Komorowski, et al.October 28, 2016
- ArticleRisk of relapse after natalizumab withdrawalResults from the French TYSEDMUS cohortCaroline Papeix, Sandra Vukusic, Romain Casey, et al.October 28, 2016
- ArticleIncreased prevalence of autoimmune disease within C9 and FTD/MND cohortsCompleting the pictureZachary A. Miller, Virginia E. Sturm, Gamze Balci Camsari, et al.October 28, 2016
Pages
Advertisement
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease
Dr. Rizwan S. Akhtar and Dr. Sarah Brooker